Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20458050 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Intervention: Drug: cediranib maleate

Indicates status has not been verified in more than two years